EP2929041A4 - Omega-3 pentaenoic acid compositions and methods of use - Google Patents

Omega-3 pentaenoic acid compositions and methods of use

Info

Publication number: EP2929041A4
Authority: EP; European Patent Office
Prior art keywords: omega; methods; acid compositions; pentaenoic acid; pentaenoic
Prior art date: 2012-12-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP13861394.8A

Other languages

German (de)

French (fr)

Other versions

EP2929041A1 (en

Inventor

George Bobotas

Abdel Aziz Fawzy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Matinas Biopharma Inc

Original Assignee

Matinas Biopharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-12-06

Filing date

2013-12-06

Publication date

2016-06-08

2013-12-06 Application filed by Matinas Biopharma Inc filed Critical Matinas Biopharma Inc

2013-12-06 Priority to EP21170003.4A priority Critical patent/EP3888646A1/en

2015-10-14 Publication of EP2929041A1 publication Critical patent/EP2929041A1/en

2016-06-08 Publication of EP2929041A4 publication Critical patent/EP2929041A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/06—Preservation of finished products
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0007—Organic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Polymers & Plastics (AREA)
Food Science & Technology (AREA)
Biochemistry (AREA)
Wood Science & Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Zoology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Botany (AREA)
Emergency Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Biotechnology (AREA)
Microbiology (AREA)

EP13861394.8A 2012-12-06 2013-12-06 Omega-3 pentaenoic acid compositions and methods of use Withdrawn EP2929041A4 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
EP21170003.4A EP3888646A1 (en)	2012-12-06	2013-12-06	Omega-3 pentaenoic acid compositions and methods of use

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201261734331P	2012-12-06	2012-12-06
US201361780948P	2013-03-13	2013-03-13
PCT/US2013/073701 WO2014089501A1 (en)	2012-12-06	2013-12-06	Omega-3 pentaenoic acid compositions and methods of use

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
EP21170003.4A Division EP3888646A1 (en)	2012-12-06	2013-12-06	Omega-3 pentaenoic acid compositions and methods of use

Publications (2)

Publication Number	Publication Date
EP2929041A1 EP2929041A1 (en)	2015-10-14
EP2929041A4 true EP2929041A4 (en)	2016-06-08

Family

ID=50884050

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
EP21170003.4A Withdrawn EP3888646A1 (en)	2012-12-06	2013-12-06	Omega-3 pentaenoic acid compositions and methods of use
EP13861394.8A Withdrawn EP2929041A4 (en)	2012-12-06	2013-12-06	Omega-3 pentaenoic acid compositions and methods of use
EP13861305.4A Withdrawn EP2928462A4 (en)	2012-12-06	2013-12-06	Methods of administering compositions comprising docosapentaenoic acid

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
EP21170003.4A Withdrawn EP3888646A1 (en)	2012-12-06	2013-12-06	Omega-3 pentaenoic acid compositions and methods of use

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
EP13861305.4A Withdrawn EP2928462A4 (en)	2012-12-06	2013-12-06	Methods of administering compositions comprising docosapentaenoic acid

Country Status (9)

Country	Link
EP (3)	EP3888646A1 (en)
JP (4)	JP2016501249A (en)
KR (3)	KR20210059779A (en)
CN (4)	CN104937103A (en)
AU (7)	AU2013354979A1 (en)
CA (2)	CA2894183A1 (en)
IN (2)	IN2015MU01505A (en)
MX (2)	MX2015007085A (en)
WO (2)	WO2014089511A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR101568665B1 (en)	2015-07-21	2015-11-12	디와이오토 주식회사	Brush structure for increasing ripple current of motor
WO2018001844A1 (en) *	2016-06-28	2018-01-04	Nestec S.A.	Biomarkers of blood-brain barrier dysfunction
JP2018168139A (en) *	2016-10-21	2018-11-01	マルハニチロ株式会社	Composition for reducing neutral fat values or inhibiting a rise thereof, containing n-3 unsaturated fatty acid, and use of n-3 unsaturated fatty acid in the production of the composition
JP7099821B2 (en) *	2017-12-20	2022-07-12	ポッカサッポロフード＆ビバレッジ株式会社	PCSK9 inhibitor and food composition for improving cholesterol metabolism
EP3586640A1 (en)	2018-06-21	2020-01-01	Nuseed Pty Ltd	Dha enriched polyunsaturated fatty acid compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1714564A1 (en) *	2005-04-21	2006-10-25	N.V. Nutricia	Method for treatment and prevention of respiratory insufficiency
WO2008032949A1 (en) *	2006-09-14	2008-03-20	Ilshin Wells Co., Ltd.	Glyceride oil composition from fish oil and preparation method thereof
US20110071090A1 (en) *	2009-03-11	2011-03-24	Stable Solutions Llc	Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
WO2013192109A1 (en) *	2012-06-17	2013-12-27	Matinas Biopharma, Inc.	Omega-3 pentaenoic acid compositions and methods of use

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8819110D0 (en)	1988-08-11	1988-09-14	Norsk Hydro As	Antihypertensive drug & method for production
GB9901809D0 (en) *	1999-01-27	1999-03-17	Scarista Limited	Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes
GB0016045D0 (en)	2000-06-29	2000-08-23	Laxdale Limited	Therapeutic combinations of fatty acids
JP2002125618A (en) *	2000-10-30	2002-05-08	Katsuyuki Wakatsuki	Health food
WO2007058523A1 (en)	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
JP5658876B2 (en) *	2006-07-05	2015-01-28	フォトンズコーポレーションリミテッド	Ultra high purity EPA and polar lipids produced in large-scale heterotrophic culture areas
PH12019500030A1 (en) *	2009-03-09	2020-02-10	Pronova Biopharma Norge As	Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
EP3278665B1 (en) *	2009-04-29	2020-09-09	Amarin Pharmaceuticals Ireland Limited	Stable pharmaceutical composition and methods of using same
CN108096209A (en) *	2009-06-15	2018-06-01	阿马里纳制药公司	Triglycerides, composition and method without increasing LDL-C levels are reduced in the object of associated Statins therapy
WO2012112511A1 (en) *	2011-02-16	2012-08-23	Pivotal Therapeutics, Inc.	Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
EP2675445A1 (en) *	2011-02-16	2013-12-25	Pivotal Therapeutics, Inc.	Statin and omega 3 fatty acids (epa, dha and dpa) for use in cardiovascular diseases

2013
- 2013-12-06 AU AU2013354979A patent/AU2013354979A1/en not_active Abandoned
- 2013-12-06 JP JP2015545896A patent/JP2016501249A/en active Pending
- 2013-12-06 CA CA2894183A patent/CA2894183A1/en not_active Abandoned
- 2013-12-06 CA CA2894366A patent/CA2894366A1/en not_active Abandoned
- 2013-12-06 CN CN201380063980.3A patent/CN104937103A/en active Pending
- 2013-12-06 JP JP2015545894A patent/JP6881893B2/en active Active
- 2013-12-06 CN CN202110585483.6A patent/CN113274378A/en active Pending
- 2013-12-06 WO PCT/US2013/073714 patent/WO2014089511A2/en active Application Filing
- 2013-12-06 CN CN202010984870.2A patent/CN112107570A/en active Pending
- 2013-12-06 MX MX2015007085A patent/MX2015007085A/en unknown
- 2013-12-06 MX MX2015007082A patent/MX2015007082A/en unknown
- 2013-12-06 CN CN201380064003.5A patent/CN104902888A/en active Pending
- 2013-12-06 KR KR1020217013255A patent/KR20210059779A/en active IP Right Grant
- 2013-12-06 WO PCT/US2013/073701 patent/WO2014089501A1/en active Application Filing
- 2013-12-06 KR KR1020157017202A patent/KR20150103009A/en not_active Application Discontinuation
- 2013-12-06 AU AU2013354969A patent/AU2013354969A1/en not_active Abandoned
- 2013-12-06 KR KR1020157016331A patent/KR20150103671A/en not_active Application Discontinuation
- 2013-12-06 EP EP21170003.4A patent/EP3888646A1/en not_active Withdrawn
- 2013-12-06 EP EP13861394.8A patent/EP2929041A4/en not_active Withdrawn
- 2013-12-06 EP EP13861305.4A patent/EP2928462A4/en not_active Withdrawn
2015
- 2015-06-10 IN IN1505MU2015 patent/IN2015MU01505A/xx unknown
- 2015-06-10 IN IN5009DE2015 patent/IN2015DE05009A/xx unknown
2017
- 2017-09-22 AU AU2017232203A patent/AU2017232203A1/en not_active Abandoned
2018
- 2018-09-12 AU AU2018229440A patent/AU2018229440A1/en not_active Abandoned
2019
- 2019-06-20 JP JP2019114492A patent/JP2019172697A/en active Pending
- 2019-08-14 AU AU2019216634A patent/AU2019216634A1/en not_active Abandoned
2020
- 2020-06-03 AU AU2020203658A patent/AU2020203658A1/en not_active Abandoned
2021
- 2021-03-24 AU AU2021201865A patent/AU2021201865A1/en not_active Abandoned
- 2021-05-19 JP JP2021084578A patent/JP2021120407A/en active Pending

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1714564A1 (en) *	2005-04-21	2006-10-25	N.V. Nutricia	Method for treatment and prevention of respiratory insufficiency
WO2008032949A1 (en) *	2006-09-14	2008-03-20	Ilshin Wells Co., Ltd.	Glyceride oil composition from fish oil and preparation method thereof
US20110071090A1 (en) *	2009-03-11	2011-03-24	Stable Solutions Llc	Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
WO2013192109A1 (en) *	2012-06-17	2013-12-27	Matinas Biopharma, Inc.	Omega-3 pentaenoic acid compositions and methods of use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2014089501A1 *

Also Published As

Publication number	Publication date
KR20150103009A (en)	2015-09-09
AU2013354969A1 (en)	2015-06-11
WO2014089511A2 (en)	2014-06-12
WO2014089501A1 (en)	2014-06-12
IN2015DE05009A (en)	2015-12-18
KR20150103671A (en)	2015-09-11
AU2017232203A1 (en)	2017-10-12
MX2015007085A (en)	2016-01-12
CN104937103A (en)	2015-09-23
CN104902888A (en)	2015-09-09
AU2018229440A1 (en)	2018-10-04
EP2928462A2 (en)	2015-10-14
JP6881893B2 (en)	2021-06-02
AU2021201865A1 (en)	2021-04-22
CA2894366A1 (en)	2014-06-12
EP3888646A1 (en)	2021-10-06
MX2015007082A (en)	2016-01-12
IN2015MU01505A (en)	2016-05-27
JP2019172697A (en)	2019-10-10
CA2894183A1 (en)	2014-06-12
AU2020203658A1 (en)	2020-06-25
AU2019216634A1 (en)	2019-09-05
JP2016501249A (en)	2016-01-18
JP2016501248A (en)	2016-01-18
WO2014089511A3 (en)	2014-07-31
KR20210059779A (en)	2021-05-25
JP2021120407A (en)	2021-08-19
AU2013354979A1 (en)	2015-06-11
CN113274378A (en)	2021-08-20
CN112107570A (en)	2020-12-22
EP2929041A1 (en)	2015-10-14
EP2928462A4 (en)	2016-06-01

Legal Events

Date	Code	Title	Description
2015-09-11	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2015-10-14	17P	Request for examination filed	Effective date: 20150602
2015-10-14	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2015-10-14	AX	Request for extension of the european patent	Extension state: BA ME
2016-03-16	DAX	Request for extension of the european patent (deleted)
2016-06-08	RA4	Supplementary search report drawn up and despatched (corrected)	Effective date: 20160506
2016-06-08	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/40 20060101ALI20160429BHEP Ipc: A61K 31/202 20060101ALI20160429BHEP Ipc: A61K 31/225 20060101AFI20160429BHEP Ipc: A23D 9/00 20060101ALI20160429BHEP Ipc: C11B 5/00 20060101ALI20160429BHEP Ipc: A61K 9/48 20060101ALI20160429BHEP Ipc: A23D 9/06 20060101ALI20160429BHEP
2020-05-01	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2020-06-03	17Q	First examination report despatched	Effective date: 20200507
2020-11-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: EXAMINATION IS IN PROGRESS
2022-10-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2022-11-23	18D	Application deemed to be withdrawn	Effective date: 20220701

Publication	Publication Date	Title
EP2861227A4 (en)	2016-01-27	Omega-3 pentaenoic acid compositions and methods of use
HK1212701A1 (en)	2016-06-17	Formulations of enzalutamide
AP3965A (en)	2016-12-24	Anthelminitic compounds and compositions and method of using thereof
ZA201508059B (en)	2016-12-21	Compositions and methods of use of phorbol esters
EP3735963C0 (en)	2023-09-13	Self-emulsifying composition of omega-3 fatty acid
SG11201404930SA (en)	2014-09-26	Post-cmp removal using compositions and method of use
SG10201800243XA (en)	2018-02-27	SELF-EMULSIFYING COMPOSITION OF ω-3 FATTY ACID
EP2827868A4 (en)	2015-11-11	Pharmaaceutical compositions comprising fatty acid esters
EP2917314A4 (en)	2016-06-29	Composition of oligomerate
EP2895586A4 (en)	2016-06-15	Detergent composition comprising phosphinosuccinic acid adducts and methods of use
EP2906041A4 (en)	2016-10-26	Compositions and methods of use of an inappetance-controlling compound
EP2968246A4 (en)	2016-08-03	Omega-3 pentaenoic acid compositions and methods of use
EP2929041A4 (en)	2016-06-08	Omega-3 pentaenoic acid compositions and methods of use
IL245588A0 (en)	2016-06-30	Solid compositions of triglycerides and uses thereof
EP2852370A4 (en)	2016-02-17	Radiance compositions and methods of use
EP2809337A4 (en)	2016-05-11	ß-ARRESTIN EFFECTORS AND COMPOSITIONS AND METHODS OF USE THEREOF
EP2751071A4 (en)	2015-09-30	Fatty acid amides, compositions and methods of use
HK1212164A1 (en)	2016-06-10	Beta-hydroxy-beta-methylbutryic acid- containing compositions and uses thereof ---
EP2859071A4 (en)	2016-02-10	Chemical compositions and methods of using same
IL239623A0 (en)	2015-08-31	Methods and compositions for admisitration of oxybutynin
EP2841164A4 (en)	2015-12-02	Dermal-appropriate compositions and methods of use
GB201208974D0 (en)	2012-07-04	Improvements in the manufacture of fatty acids
AU2012904573A0 (en)	2012-11-01	Nutritional Compositions and Methods of Manufacture